Zymeworks Inc. (ZYME) is a publicly traded Healthcare sector company. As of August 25, 2026, ZYME trades at $28.06 with a market cap of $2.05B and a P/E ratio of -14.28. ZYME moved -3.24% today. Year to date, ZYME is +8.89%; over the trailing twelve months it is +99.24%. Its 52-week range spans $9.03 to $29.75. Analyst consensus is strong buy with an average price target of $40.33. Rallies surfaces ZYME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Zymeworks Inc. (ZYME) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ZYME moved -3.24% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $28.06 |
| Market Cap | $2.05B |
| P/E Ratio | -14.28 |
| EPS | $-2.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.75 |
| 52-Week Low | $9.03 |
| Volume | 293.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $37.13M |
| Net Income | $-149.99M |
| Gross Margin | 0.00% |
9 analysts cover ZYME: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.33.